nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—NFKB1—type 2 diabetes mellitus	0.198	0.558	CbGaD
Pranlukast—Candesartan—Irbesartan—type 2 diabetes mellitus	0.131	0.389	CrCrCtD
Pranlukast—Candesartan—Valsartan—type 2 diabetes mellitus	0.111	0.33	CrCrCtD
Pranlukast—Candesartan—Losartan—type 2 diabetes mellitus	0.0946	0.281	CrCrCtD
Pranlukast—ABCC2—type 2 diabetes mellitus	0.0666	0.188	CbGaD
Pranlukast—TNF—type 2 diabetes mellitus	0.0607	0.171	CbGaD
Pranlukast—CYP3A4—type 2 diabetes mellitus	0.0294	0.083	CbGaD
Pranlukast—ABCC2—Glyburide—type 2 diabetes mellitus	0.0181	0.083	CbGbCtD
Pranlukast—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0165	0.0753	CbGbCtD
Pranlukast—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0151	0.0689	CbGbCtD
Pranlukast—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.014	0.064	CbGbCtD
Pranlukast—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0119	0.0545	CbGbCtD
Pranlukast—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0119	0.0545	CbGbCtD
Pranlukast—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.011	0.0503	CbGbCtD
Pranlukast—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0107	0.0491	CbGbCtD
Pranlukast—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0106	0.0485	CbGbCtD
Pranlukast—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00971	0.0444	CbGbCtD
Pranlukast—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00958	0.0438	CbGbCtD
Pranlukast—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00903	0.0413	CbGbCtD
Pranlukast—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00876	0.0401	CbGbCtD
Pranlukast—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00865	0.0396	CbGbCtD
Pranlukast—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00766	0.035	CbGbCtD
Pranlukast—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00692	0.0317	CbGbCtD
Pranlukast—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0061	0.0279	CbGbCtD
Pranlukast—CYP2C9—Losartan—type 2 diabetes mellitus	0.00558	0.0255	CbGbCtD
Pranlukast—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00525	0.024	CbGbCtD
Pranlukast—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00503	0.023	CbGbCtD
Pranlukast—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00503	0.023	CbGbCtD
Pranlukast—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00476	0.0218	CbGbCtD
Pranlukast—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00354	0.0162	CbGbCtD
Pranlukast—CYP3A4—Losartan—type 2 diabetes mellitus	0.00324	0.0148	CbGbCtD
Pranlukast—MUC2—pancreas—type 2 diabetes mellitus	0.000846	0.135	CbGeAlD
Pranlukast—NFKB1—islet of Langerhans—type 2 diabetes mellitus	0.000686	0.11	CbGeAlD
Pranlukast—MUC2—liver—type 2 diabetes mellitus	0.000538	0.0861	CbGeAlD
Pranlukast—NFKB1—cardiovascular system—type 2 diabetes mellitus	0.000496	0.0793	CbGeAlD
Pranlukast—NFKB1—kidney—type 2 diabetes mellitus	0.000485	0.0776	CbGeAlD
Pranlukast—CYSLTR1—pancreas—type 2 diabetes mellitus	0.000474	0.0758	CbGeAlD
Pranlukast—NFKB1—cortex of kidney—type 2 diabetes mellitus	0.000473	0.0756	CbGeAlD
Pranlukast—NFKB1—adipose tissue—type 2 diabetes mellitus	0.000438	0.07	CbGeAlD
Pranlukast—CYSLTR1—adipose tissue—type 2 diabetes mellitus	0.00043	0.0687	CbGeAlD
Pranlukast—NFKB1—liver—type 2 diabetes mellitus	0.000307	0.0491	CbGeAlD
Pranlukast—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000217	0.0347	CbGeAlD
Pranlukast—ABCC2—kidney—type 2 diabetes mellitus	0.000191	0.0305	CbGeAlD
Pranlukast—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000186	0.0297	CbGeAlD
Pranlukast—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.00013	0.0208	CbGeAlD
Pranlukast—ABCC2—liver—type 2 diabetes mellitus	0.00012	0.0193	CbGeAlD
Pranlukast—CYP3A4—kidney—type 2 diabetes mellitus	9.68e-05	0.0155	CbGeAlD
Pranlukast—CYP2C9—liver—type 2 diabetes mellitus	8.03e-05	0.0128	CbGeAlD
Pranlukast—CYP3A4—liver—type 2 diabetes mellitus	6.12e-05	0.00979	CbGeAlD
Pranlukast—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	4.09e-06	4.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRS1—type 2 diabetes mellitus	4.09e-06	4.88e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—type 2 diabetes mellitus	4.08e-06	4.87e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SRC—type 2 diabetes mellitus	4.04e-06	4.82e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NFKB1—type 2 diabetes mellitus	4.03e-06	4.82e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	3.95e-06	4.72e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.93e-06	4.7e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.93e-06	4.7e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.92e-06	4.68e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.92e-06	4.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.92e-06	4.68e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT1—type 2 diabetes mellitus	3.88e-06	4.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.88e-06	4.63e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	3.86e-06	4.61e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	3.86e-06	4.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CASP8—type 2 diabetes mellitus	3.85e-06	4.6e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AVP—type 2 diabetes mellitus	3.83e-06	4.57e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.83e-06	4.57e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—type 2 diabetes mellitus	3.82e-06	4.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.81e-06	4.55e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.79e-06	4.53e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT2—type 2 diabetes mellitus	3.78e-06	4.52e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	3.76e-06	4.49e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SRC—type 2 diabetes mellitus	3.76e-06	4.49e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.7e-06	4.42e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.69e-06	4.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.68e-06	4.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—type 2 diabetes mellitus	3.67e-06	4.38e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—type 2 diabetes mellitus	3.66e-06	4.37e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.64e-06	4.35e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.61e-06	4.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	3.59e-06	4.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	3.59e-06	4.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	3.59e-06	4.28e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.54e-06	4.23e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.53e-06	4.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.46e-06	4.13e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	3.45e-06	4.12e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	3.45e-06	4.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	3.44e-06	4.11e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	3.44e-06	4.11e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PIK3R1—type 2 diabetes mellitus	3.43e-06	4.1e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—type 2 diabetes mellitus	3.36e-06	4.01e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.36e-06	4.01e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.33e-06	3.97e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—type 2 diabetes mellitus	3.32e-06	3.97e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.31e-06	3.96e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	3.31e-06	3.95e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	3.31e-06	3.95e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.3e-06	3.95e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2—type 2 diabetes mellitus	3.3e-06	3.94e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—type 2 diabetes mellitus	3.29e-06	3.93e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	3.27e-06	3.91e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	3.27e-06	3.91e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.25e-06	3.89e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	3.25e-06	3.88e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.25e-06	3.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RELA—type 2 diabetes mellitus	3.23e-06	3.86e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	3.2e-06	3.82e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	3.2e-06	3.82e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	3.2e-06	3.82e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—C3—type 2 diabetes mellitus	3.18e-06	3.8e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.14e-06	3.75e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	3.12e-06	3.73e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.11e-06	3.71e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.1e-06	3.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—type 2 diabetes mellitus	3.07e-06	3.66e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.05e-06	3.64e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.03e-06	3.62e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.03e-06	3.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.02e-06	3.61e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	3.01e-06	3.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.97e-06	3.55e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.96e-06	3.54e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.96e-06	3.54e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.96e-06	3.53e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—type 2 diabetes mellitus	2.94e-06	3.51e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.93e-06	3.5e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.9e-06	3.46e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.89e-06	3.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	2.88e-06	3.44e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	2.88e-06	3.44e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.82e-06	3.37e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	2.82e-06	3.36e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.81e-06	3.36e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.79e-06	3.33e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.78e-06	3.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	2.78e-06	3.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	2.78e-06	3.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	2.78e-06	3.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	2.78e-06	3.32e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—type 2 diabetes mellitus	2.72e-06	3.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	2.72e-06	3.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	2.72e-06	3.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	2.72e-06	3.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	2.72e-06	3.25e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—type 2 diabetes mellitus	2.71e-06	3.23e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	2.7e-06	3.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.64e-06	3.15e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.61e-06	3.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	2.61e-06	3.11e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.6e-06	3.11e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.59e-06	3.09e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	2.55e-06	3.04e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	2.55e-06	3.04e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.54e-06	3.03e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SRC—type 2 diabetes mellitus	2.54e-06	3.03e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.53e-06	3.02e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—type 2 diabetes mellitus	2.53e-06	3.02e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.53e-06	3.02e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.51e-06	3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.49e-06	2.97e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.48e-06	2.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	2.48e-06	2.96e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.45e-06	2.93e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.45e-06	2.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.44e-06	2.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	2.42e-06	2.89e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	2.37e-06	2.83e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	2.37e-06	2.83e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	2.37e-06	2.83e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—type 2 diabetes mellitus	2.34e-06	2.79e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.32e-06	2.77e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	2.27e-06	2.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	2.27e-06	2.71e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	2.26e-06	2.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—type 2 diabetes mellitus	2.22e-06	2.66e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.22e-06	2.65e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.22e-06	2.65e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	2.22e-06	2.65e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	2.22e-06	2.65e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	2.18e-06	2.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	2.18e-06	2.61e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	2.17e-06	2.6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.16e-06	2.58e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	2.16e-06	2.58e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	2.16e-06	2.58e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	2.16e-06	2.58e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	2.15e-06	2.56e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.15e-06	2.56e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.11e-06	2.52e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.11e-06	2.52e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.11e-06	2.52e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	2.11e-06	2.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.09e-06	2.49e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	2.08e-06	2.49e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.98e-06	2.37e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.95e-06	2.33e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.94e-06	2.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.94e-06	2.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.94e-06	2.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.94e-06	2.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.9e-06	2.27e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.88e-06	2.25e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.88e-06	2.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.86e-06	2.22e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.86e-06	2.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.84e-06	2.2e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.8e-06	2.15e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.79e-06	2.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.79e-06	2.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.79e-06	2.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.79e-06	2.14e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.78e-06	2.13e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.77e-06	2.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.75e-06	2.09e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.75e-06	2.09e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.72e-06	2.05e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—type 2 diabetes mellitus	1.71e-06	2.04e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.71e-06	2.04e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.7e-06	2.03e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.68e-06	2.01e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.68e-06	2.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.64e-06	1.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.6e-06	1.91e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.6e-06	1.91e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—type 2 diabetes mellitus	1.58e-06	1.88e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.49e-06	1.78e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.47e-06	1.75e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.46e-06	1.75e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.46e-06	1.75e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.45e-06	1.73e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.45e-06	1.73e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.44e-06	1.72e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.44e-06	1.72e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.43e-06	1.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.42e-06	1.7e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.42e-06	1.7e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.42e-06	1.7e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.42e-06	1.7e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.42e-06	1.69e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.39e-06	1.66e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.38e-06	1.65e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.37e-06	1.64e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.34e-06	1.6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.32e-06	1.57e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.29e-06	1.54e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.29e-06	1.54e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.28e-06	1.53e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.28e-06	1.53e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.28e-06	1.53e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.25e-06	1.5e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.25e-06	1.5e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.24e-06	1.48e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.24e-06	1.48e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.22e-06	1.45e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.19e-06	1.42e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.17e-06	1.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.16e-06	1.39e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.16e-06	1.38e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.16e-06	1.38e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.13e-06	1.35e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.11e-06	1.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.11e-06	1.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.11e-06	1.32e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.11e-06	1.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.1e-06	1.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.09e-06	1.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-06	1.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	9.62e-07	1.15e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	9.55e-07	1.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.55e-07	1.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	9.51e-07	1.14e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	9.44e-07	1.13e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	9.38e-07	1.12e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	9.1e-07	1.09e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	8.86e-07	1.06e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	8.69e-07	1.04e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	8.65e-07	1.03e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	8.51e-07	1.02e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	8.48e-07	1.01e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	8.28e-07	9.89e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	8.28e-07	9.89e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	8.26e-07	9.86e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	8.16e-07	9.74e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	7.83e-07	9.35e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	7.68e-07	9.17e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	7.57e-07	9.04e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	7.44e-07	8.88e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	7.31e-07	8.73e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	7.29e-07	8.7e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.2e-07	8.6e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.35e-07	7.58e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.23e-07	7.43e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.71e-07	6.82e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.46e-07	6.52e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.46e-07	6.52e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.99e-07	5.96e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.81e-07	4.54e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.51e-07	3e-06	CbGpPWpGaD
